Serveur d'exploration sur l'opéra - Curation (PubMed)

Index « MedMesh.i » - entrée « Adalimumab »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Acylation < Adalimumab < Adaptation, Physiological  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000080 (????) Stinne Ravn Greisen [Danemark] ; Holger Jon M Ller [Danemark] ; Kristian Stengaard-Pedersen [Danemark] ; Merete Lund Hetland [Danemark] ; Kim H Rslev-Petersen [Danemark] ; Peter Junker [Danemark] ; Mikkel Stergaard [Danemark] ; Malene Hvid [Danemark] ; Bent Deleuran [Danemark]Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
000139 (2014) Stinne Ravn Greisen ; Karen Kr Mmer Schelde ; Tue Kruse Rasmussen ; Tue Wenzel Kragstrup ; Kristian Stengaard-Pedersen ; Merete Lund Hetland ; Kim H Rslev-Petersen ; Peter Junker ; Mikkel Stergaard ; Bent Deleuran ; Malene HvidCXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'.
000181 (2015) Mette Bj Rndal Axelsen [Danemark] ; Iris Eshed [Israël] ; Kim H Rslev-Petersen [Danemark] ; Kristian Stengaard-Pedersen [Danemark] ; Merete Lund Hetland [Danemark] ; Jakob M Ller [Danemark] ; Peter Junker [Danemark] ; Jan P Denphant [Danemark] ; Annette Schlemmer [Danemark] ; Torkell Ellingsen [Danemark] ; Palle Ahlquist [Danemark] ; Hanne Lindegaard [Danemark] ; Asta Linauskas [Danemark] ; Mette Yde Dam [Danemark] ; Ib Hansen [Danemark] ; Hans Christian Horn [Danemark] ; Christian Gytz Ammitzb Ll [Danemark] ; Anette J Rgensen [Danemark] ; Sophine B. Krintel [Danemark] ; Johnny Raun [Danemark] ; Niels S. Krogh [Danemark] ; Julia Sidenius Johansen [Danemark] ; Mikkel Stergaard [Danemark]A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
000240 (2014) Kim H Rslev-Petersen [Danemark] ; Merete Lund Hetland ; Peter Junker ; Jan P Denphant ; Torkell Ellingsen ; Palle Ahlquist ; Hanne Lindegaard ; Asta Linauskas ; Annette Schlemmer ; Mette Yde Dam ; Ib Hansen ; Hans Christian Horn ; Christian Gytz Ammitzb Ll ; Anette J Rgensen ; Sophine B. Krintel ; Johnny Raun ; Julia S. Johansen ; Mikkel Stergaard ; Kristian Stengaard-PedersenAdalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Adalimumab" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Adalimumab" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    OperaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Adalimumab
}}

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu Apr 14 14:59:05 2016. Site generation: Thu Jan 4 23:09:23 2024